HUS1 Human

HUS1 Checkpoint Homolog Human Recombinant
Shipped with Ice Packs
In Stock

Description

Checkpoint Activation

HUS1 is critical for activating ATR-mediated checkpoints in response to DNA damage. The 9-1-1 complex recruits Rad17-RFC to load onto chromatin, facilitating phosphorylation of checkpoint kinases (e.g., Chk1) and stabilizing replication forks . Key findings:

  • Meiotic Function: In germ cells, Hus1 knockout causes persistent meiotic DNA damage, impaired double-strand break (DSB) repair, and chromosomal defects .

  • ATR Dependency: HUS1-deficient cells fail to localize RAD9 to meiotic chromosomes but retain RAD1 foci on unsynapsed chromatin, suggesting independent roles for RAD1 in monitoring chromatin state .

DNA Repair

HUS1 enhances base excision repair (BER) by interacting with NEIL1, a glycosylase for oxidized DNA bases. Residues 290–350 of NEIL1 mediate binding to HUS1, Rad9, and Rad1, stimulating NEIL1’s glycosylase activity ~5-fold .

Repair PathwayHUS1 InteractionFunctional Outcome
BERBinds NEIL1, Rad9, Rad1Enhances glycosylase activity
MMEJInteracts with MSH2/MSH3Facilitates mismatch repair
DNA Damage SensingLocalizes to ssDNA via RPATriggers checkpoint signaling

Oncogenic Potential

HUS1 acts as an oncogene in urothelial cancer (UC), correlating with poor prognosis. Studies in UC cell lines (UM-UC-3, HT1197) show:

  • Cisplatin Sensitivity: HUS1 knockdown inhibits proliferation in cisplatin-sensitive cells but fails to resensitize resistant cells .

  • Prognostic Marker: High HUS1 expression in UC patients predicts reduced survival, emphasizing its role in chemoresistance .

Tumor-Suppressive Roles

In hepatocellular carcinoma, HUS1 acts as a tumor suppressor, with downregulated expression linked to aggressive phenotypes . This dual functionality underscores context-dependent roles in cancer.

Protein Partners

PartnerInteraction SiteFunctional Impact
HDAC1Direct bindingModulates G2/M checkpoint control
Jab1Physical associationMediates cytoplasmic translocation and degradation
MYHElectrostatic interactionsStabilizes mismatch repair
Rad17Indirect (via Rad1)Facilitates chromatin loading

Post-Translational Regulation

HUS1 is regulated by:

  • Jab1-Mediated Degradation: Jab1 interaction promotes 9-1-1 complex turnover, dampening checkpoint signaling .

  • Phosphorylation: ATR-dependent phosphorylation enhances HUS1’s recruitment to DNA damage sites .

Research Challenges and Future Directions

  1. Therapeutic Targeting:

    • HUS1 Inhibitors: siRNA-mediated knockdown in UC models shows promise but requires validation in patient-derived xenografts .

    • Combination Therapies: Enhancing cisplatin efficacy by targeting HUS1 in resistant UC cells remains unexplored.

  2. Structural Insights:

    • IDCL Dynamics: The αII1–βII2 loop in Rad9 and αI2–βI7 loop in Rad1 may enable DNA binding via conformational changes .

  3. Germline Stability:

    • Hus1 knockout in mice causes meiotic failure, highlighting its role in maintaining genomic integrity in the germline .

Product Specs

Introduction
HUS1 is an essential part of a checkpoint complex that is activated by genotoxins and has been conserved throughout evolution. This protein interacts with Rad9 and Rad1 to form a complex known as 9-1-1 (RAD9-RAD1-HUS1), which binds to damaged DNA. The 9-1-1 complex plays a crucial role in promoting DNA damage signaling and repair. It also contributes to apoptosis and cell cycle arrest when necessary. Structurally, the trimeric complex resembles the proliferating cell nuclear antigen (PCNA) sliding clamp. It interacts with Rad17, forming a clamp-clamp loader pair, during the DNA damage response.
Description
HUS1, a protein produced in E. coli, is a single polypeptide chain that lacks glycosylation. It consists of 300 amino acids (specifically, amino acids 1 to 280) and has a molecular weight of 33.8 kDa. A 20 amino acid His-tag is fused to the N-terminus of HUS1 to facilitate purification, which is achieved using proprietary chromatographic methods.
Physical Appearance
A clear solution that has been sterilized through filtration.
Formulation
The HUS1 protein solution has a concentration of 0.25 mg/ml and is formulated in a buffer containing 20 mM Tris-HCl (pH 8.0), 100 mM NaCl, and 40% glycerol.
Purity
The purity of the HUS1 protein is greater than 95%, as determined by SDS-PAGE analysis.
Stability
For short-term storage (2-4 weeks), the HUS1 protein should be kept at 4°C. For longer storage, it is recommended to freeze the protein at -20°C. Repeated freezing and thawing of the protein should be avoided.
Synonyms
HUS1 Checkpoint Homolog (S. pombe), Checkpoint Protein HUS1, Hus1+-like protein.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MKFRAKIVDG ACLNHFTRIS NMIAKLAKTC TLRISPDKLN FILCDKLANG GVSMWCELEQ ENFFNEFQME GVSAENNEIY LELTSENLSR ALKTAQNARA LKIKLTNKHF PCLTVSVELL SMSSSSRIVT HDIPIKVIPR KLWKDLQEPV VPDPDVSIYL PVLKTMKSVV EKMKNISNHL VIEANLDGEL NLKIETELVC VTTHFKDLGN PPLASESTHE DRNVEHMAEV HIDIRKLLQF LAGQQVNPTK ALCNIVNNKM VHFDLLHEDV SLQYFIPALS

Q&A

What is the HUS1 protein and what is its primary function in human cells?

HUS1 is an evolutionarily conserved protein essential for checkpoint control mechanisms in human cells. It forms a heterotrimeric complex with RAD1 and RAD9 proteins that plays a crucial role in DNA damage response pathways. The complex functions as a DNA damage sensor and signal transducer, helping to coordinate cellular responses to genotoxic stress. Computational studies have predicted structural similarity between the individual proteins of the HUS1-RAD1-RAD9 complex and the replication processivity factor PCNA, suggesting that the complex may form a PCNA-like ring structure and function as a sliding clamp during checkpoint control .

How evolutionarily conserved is the HUS1 protein structure across species?

The HUS1 protein demonstrates remarkable evolutionary conservation from yeast to humans, indicating its fundamental importance in cellular processes. In fission yeast (Schizosaccharomyces pombe), the Hus1-Rad1-Rad9 complex has been extensively studied, showing functional and structural parallels with human counterparts. While some regions show high sequence conservation across species, the complex also possesses unique structural and functional features not explained by PCNA alignment, suggesting specialized adaptations in different organisms .

What experimental evidence supports the structural model of the HUS1-RAD1-RAD9 complex?

The structural model proposing that HUS1-RAD1-RAD9 forms a PCNA-like ring is supported by several lines of evidence:

  • Computational alignment studies showing structural similarities with PCNA

  • Protein interaction studies demonstrating stable complex formation

  • Functional studies showing the complex works as a unit in checkpoint responses

What screening methods are effective for identifying functional domains in HUS1?

Dominant-negative mutation screening has proven particularly effective for identifying functionally important residues in HUS1. This approach involves:

  • PCR mutagenesis to create a library of mutated constructs

  • Introduction of these constructs into wild-type cells using gap-repair methodology

  • Screening for checkpoint defects when the mutant proteins are overexpressed

  • Microscopic analysis to confirm cellular phenotypes (e.g., premature mitotic entry)

  • Sequence analysis to identify specific mutations

This methodology allows researchers to identify mutations that selectively disrupt specific protein-protein interactions while differentiating them from mutations that generally destabilize the protein. In one study examining fission yeast Hus1, researchers screened 20,000 transformants and identified 23 dominant-negative mutants that disrupted checkpoint control .

How can researchers effectively analyze the functional consequences of specific HUS1 mutations?

ApproachMethodologyKey ParametersApplications
Dominant-negative assaysOverexpression in wild-type cellsCell cycle arrest responseIdentifies interaction-specific defects
Complementation testsExpression in hus1Δ strainsGrowth rescueAssesses functional capacity
Protein interaction studiesCo-immunoprecipitationComplex formationMaps interaction domains
Cell cycle analysisMicroscopy following DNA damageNuclear morphologyEvaluates checkpoint function

When analyzing HUS1 mutations, it is crucial to combine multiple approaches to distinguish between general protein stability issues and specific functional defects. For example, mutations R2S, W50R, N80I, N121D, H125R, and I244M in yeast Hus1 were found to cause dominant-negative activity through targeted analyses .

How do specific amino acid substitutions in HUS1 affect its function in checkpoint control?

Sequence analysis of dominant-negative HUS1 mutants has revealed critical amino acid positions essential for proper function. In fission yeast studies, single amino acid changes including R2S, W50R, N80I, N121D, H125R, and I244M were sufficient to abolish Hus1 function while causing dominant-negative activity when overexpressed in wild-type cells. These mutations appear to allow partial complex formation but disrupt normal checkpoint signaling functions .

The pattern of mutations provides insights into structure-function relationships:

  • Some mutations occurred as single changes in multiple independent mutants

  • Certain residues (like H125) appeared in multiple mutant strains

  • Specific mutations never co-occurred, suggesting they affect similar functional domains

What methodologies are most effective for studying HUS1-RAD1-RAD9 complex assembly?

To effectively study the assembly of the HUS1-RAD1-RAD9 complex, researchers should employ a multi-faceted approach:

  • Yeast two-hybrid screening: Identifies direct protein-protein interactions between complex components

  • Co-immunoprecipitation assays: Confirms interactions in more native cellular environments

  • Structural studies: May include crystallography or cryo-EM to determine three-dimensional arrangement

  • Mutational analysis: Systematically alters amino acids to identify critical interaction sites

  • Checkpoint function assays: Tests whether complex formation correlates with functional outcomes

When designing these experiments, it's important to consider that mutations that disrupt all protein-protein interactions by generally destabilizing the protein structure will yield different results than those that selectively affect specific interactions. The latter are more informative for understanding the functional organization of the complex .

What is the relationship between HUS1 dysfunction and human disease pathology?

While the search results don't directly address human disease connections, the fundamental role of HUS1 in checkpoint control suggests significant implications for conditions associated with genomic instability. Researchers investigating these connections should consider:

  • Analyzing HUS1 mutation patterns in cancer genomic databases

  • Examining expression levels in various tumor types

  • Correlating checkpoint dysfunction with clinical outcomes

  • Developing cell line models with HUS1 variants identified in patient samples

Human subjects research involving HUS1 requires appropriate IRB approval, as it falls under human subjects research protocols. Any interaction with human subjects, including recruiting and data collection, cannot begin until the IRB has approved the research protocol and instruments .

How can researchers design effective experiments to investigate HUS1's role in DNA damage response pathways?

When designing experiments to investigate HUS1's role in DNA damage response:

  • Select appropriate damage induction: Use specific DNA-damaging agents targeting different types of damage (e.g., double-strand breaks, replication stress)

  • Employ time-course analyses: Monitor HUS1 complex formation and localization at different timepoints after damage

  • Utilize cell synchronization: To distinguish cell-cycle dependent effects

  • Combine genetic approaches: Including knockdown, knockout, and complementation with mutant variants

  • Incorporate advanced imaging: Such as live-cell microscopy to track protein dynamics

Experimental designs should clearly distinguish between HUS1's role in damage detection, signaling, and repair pathway choice. Researchers must ensure all human subjects research components receive proper IRB review, which can determine whether studies qualify for exempt or expedited review categories .

How can researchers effectively communicate their findings about HUS1 function?

Effective communication of HUS1 research findings benefits from question-asking approaches during presentations and discussions. Research shows that individuals who ask more questions, particularly follow-up questions, are perceived more positively by conversation partners . When presenting complex molecular mechanisms like HUS1 function:

  • Structure presentations to anticipate and address likely questions

  • Incorporate question prompts throughout presentations

  • Use follow-up questions to gauge understanding

  • Recognize that question-asking indicates confidence and engagement

Studies show that question-asking is associated with greater responsiveness, which encompasses listening, understanding, validation, and care. This approach is particularly valuable when discussing complex checkpoint mechanisms with interdisciplinary audiences .

What methodology questions should researchers consider when designing studies on HUS1 in human cells?

When designing studies on HUS1 in human cells, researchers should consider several methodological questions:

  • What cell types best represent the physiological context of interest?

  • How might the heterotrimeric complex formation differ between normal and disease states?

  • What controls are necessary to distinguish HUS1-specific effects from general checkpoint defects?

  • How can temporal dynamics of complex formation be accurately measured?

  • What statistical approaches are appropriate for analyzing complex protein interaction networks?

Each methodological choice should be carefully documented to enable reproducibility, and experimental designs involving human subjects or materials require proper IRB approval before any interaction with human subjects, including recruiting and data collection .

How can computational and experimental approaches be integrated to better understand HUS1 function?

Integrating computational and experimental approaches creates a powerful framework for understanding HUS1 function:

  • Structural prediction: Computational models (like the PCNA alignment) can generate testable hypotheses

  • Experimental validation: Targeted mutations can confirm or refine structural predictions

  • Systems biology: Network analyses can place HUS1 in broader signaling contexts

  • Machine learning: Can identify patterns in complex datasets from HUS1 studies

This integrated approach has already yielded insights, as seen in studies testing PCNA alignment predictions against experimental data from dominant-negative screens. While some findings are consistent with computational predictions, others reveal unique features of the HUS1-RAD1-RAD9 complex not captured by structural models alone .

What are the implications of inconsistencies between predictive models and experimental data on HUS1?

When researchers encounter inconsistencies between predictive models (like the PCNA alignment model) and experimental data about HUS1:

  • The discrepancies should be carefully documented and analyzed

  • Alternative structural or functional models should be proposed

  • More sensitive experimental techniques may be needed

  • The possibility of context-dependent functions should be considered

These inconsistencies often lead to the most significant scientific advances. For example, experiments designed to test PCNA alignment predictions for the HUS1-RAD1-RAD9 complex revealed that while some results supported the model, others indicated distinctive features not explained by the alignment, suggesting unique functional adaptations of this checkpoint complex .

The methodical approach of asking questions about these inconsistencies—particularly follow-up questions that probe deeper into initial findings—drives scientific progress and is associated with greater effectiveness in research communications .

The Art of Questioning and Scientific Discourse

karen Huang, Michael Yeomans, Alison Wood Brooks, Julia Minson, and Francesca Gino of Harvard University

Product Science Overview

Introduction

The HUS1 checkpoint homolog is a crucial component of the DNA damage response system in human cells. It plays a significant role in maintaining genomic stability by participating in the cell cycle checkpoint pathways. This article delves into the background, structure, function, and significance of the HUS1 checkpoint homolog, particularly focusing on its recombinant form.

Structure and Composition

HUS1 is a protein-coding gene that encodes a component of the 9-1-1 (RAD9-RAD1-HUS1) complex . This trimeric complex is structurally similar to the proliferating cell nuclear antigen (PCNA) sliding clamp and is involved in the DNA damage response . The HUS1 protein itself is composed of 280 amino acids and has a molecular weight of approximately 33.8 kDa .

Function and Mechanism

The primary function of HUS1 is to act as a checkpoint protein that helps in the detection and repair of DNA damage. In response to genotoxic stress, HUS1 forms a heterotrimeric complex with RAD9 and RAD1 . This 9-1-1 complex is recruited to sites of DNA lesions by the RAD17-replication factor C (RFC) clamp loader complex . Once localized to the DNA damage sites, the 9-1-1 complex acts as a sliding clamp platform for several proteins involved in long-patch base excision repair (LP-BER) .

Role in DNA Damage Response

HUS1 is an evolutionarily conserved protein that plays a pivotal role in the DNA damage response. Upon DNA damage, the 9-1-1 complex is loaded onto the chromatin, which is an early checkpoint signaling event . This process is dependent on the activation of the checkpoint kinase ATM . The complex then facilitates DNA damage signaling, repair, or apoptosis, and cell cycle arrest .

Clinical Significance

Mutations or dysregulation of HUS1 can lead to genomic instability and are associated with various diseases. For instance, HUS1 has been linked to Noonan Syndrome 2 and Deafness, Autosomal Recessive 4, with Enlarged Vestibular Aqueduct . Understanding the function and regulation of HUS1 is crucial for developing therapeutic strategies for diseases resulting from genomic instability.

Recombinant HUS1

Recombinant HUS1 is a form of the protein that is produced through recombinant DNA technology. This involves inserting the HUS1 gene into a suitable expression system, such as E. coli, to produce the protein in large quantities . Recombinant HUS1 is used in various research applications to study its function, interactions, and role in the DNA damage response.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.